E. Shirin Dason

Toronto Public Health, University of Toronto

Papers

2

Total Citations

95

H-Index

2

About

Dr. E. Shirin Dason is a leading gynecologic oncologist and researcher whose work focuses on improving the diagnosis and surgical management of complex gynecologic conditions, particularly adenomyosis and endometrial cancer. Her most impactful contribution is the authorship of "Guideline No. 437: Diagnosis and Management of Adenomyosis" (2023), which has already garnered 79 citations, establishing a standardized framework for clinicians worldwide. Dr. Dason has also advanced surgical oncology through her comparative study of laparotomy, laparoscopy, and robotic approaches for staging lymphadenectomy in high-risk endometrial cancer (2017, 16 citations), demonstrating her commitment to optimizing surgical outcomes and minimizing patient morbidity. Her research bridges evidence-based guidelines with innovative surgical techniques, directly influencing clinical practice in gynecologic oncology. With a growing citation record and a focus on translating research into actionable patient care, Dr. Dason is recognized as a key voice in her field, particularly for her work in standardizing adenomyosis management and refining surgical staging protocols.

Research Focus

Key Achievements

2
H-Index
2
Papers
95
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Guideline No. 437: Diagnosis and Management of Adenomyosis
79 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Toronto Public Health, University of Toronto

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago